Drug Profile
JTT 551
Alternative Names: JTT-551Latest Information Update: 15 Aug 2007
Price :
$50
*
At a glance
- Originator Japan Tobacco
- Class Antihyperglycaemics
- Mechanism of Action Protein-tyrosine-phosphatase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Type 2 diabetes mellitus
Most Recent Events
- 09 Aug 2007 Discontinued - Phase-I for Type-2 diabetes mellitus (PO)
- 09 Aug 2007 Discontinued - Phase-I for Type-2 diabetes mellitus in Japan (PO)
- 31 Oct 2006 Phase-I clinical trials in Type-2 diabetes mellitus (PO)